Abstract:Yun Fu, Xiaoyin Sun, Zhangyuan Gu, Zhigang Zhuang Department of Breast Surgery, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China Correspondence: Zhigang Zhuang Shanghai First Maternity and Infant Hospital, No. 2699, West Gaoke Road, Shanghai 201204, People's Republic of China Tel +86 21 20261056 Fax +86 21 20261477 Email zhuang_zg@163.com Background: Triple-negative breast cancer has become an intricate part and hotspot in the clinical and experimental research. Connexins, serving as functional proteins in gap junctions, play an important role in tumorigenesis, cell proliferation and metastasis. Methods: We constructed and employed the Connexin 43 (Cx43) overexpression lentiviral vectors and Cx43 siRNA in paclitaxel-treated MDA-MB-231 cells. We performed the experiments of clonal formation and flow cytometry to gauge the effect of paclitaxel on cellular behaviors and immunofluorescence and subsequent quantitative RT-PCR and Western blot to examine the expression of genes and corresponding proteins. Experiments of scrape loading/dye transfer were utilized to explore the gap junctions. The targets of Cx43 were identified via the experiments of co-immunoprecipitation (Co-IP), GST pull-down assays and proximal ligation assay (PLA). Results: The results showed that Cx43 hindered cell proliferation and promoted apoptosis in the paclitaxel-treated MDA-MB-231 cells. Overexpressed Cx43 suppressed the expression of resistance genes such as BRCP, Txr-1, α-tubulin and β-tubulin and promoted the expression of apoptosis gene as TSP-1 and Bcl-2. Cx43 was also positively related to ITGα 9 and negatively related to ITGαV and ITGα 11. The gap junctions altered magnificently under different expressions of Cx43, which indicated that Cx43 could promote the number of intercellular gap junctions. The immunofluorescent experiment revealed that both of Cx43 and β-tubulin were mainly localized in the cytoplasm. The assays of Co-IP and GST pull-down demonstrated that there existed a direct interaction between Cx43 and β-tubulin. Furthermore, the result of PLA also showed that Cx43 interacts with β-tubulin in MDA-MB-231 cells. Conclusion: Overexpression of Cx43 could modulate the cellular resistance to paclitaxel via targeting β-tubulin in triple-negative breast cancer. Keywords: Cx43, β-tubulin, paclitaxel, chemoresistance, gap junctions

Combination of Microtubule Associated Protein-Tau and Β-Tubulin III Predicts Chemosensitivity of Paclitaxel in Patients with Advanced Gastric Cancer.

The Relationships Between the Chemosensitivity of Human Gastric Cancer to Paclitaxel and the Expressions of Class III Β-Tubulin, MAPT, and Survivin

Correlation Between Chemotherapeutic Efficacy of Paclitaxel and Class III Β-Tubulin Protein Expression in Gastric Carcinoma Patients

Thymidine Phosphorylase/β-tubulin III Expressions Predict the Response in Chinese Advanced Gastric Cancer Patients Receiving First-Line Capecitabine Plus Paclitaxel

Serum Levels of TUBB3 Correlate with Clinical Outcome in Chinese Patients with Advanced Gastric Cancer Receiving First-Line Paclitaxel Plus Capecitabine

[Association Between ABCB1 G2677T/A Polymorphisms and Chemosensitivity of Paclitaxel in Advanced Gastric Cancer].

Expressions of Thymidylate Synthase, Thymidine Phosphorylase, Class III Β-Tubulin, and Excision Repair Cross-Complementing Group 1 Predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin

[Effect of TUBB3, TS and ERCC1 Mrna Expression on Chemoresponse and Clinical Outcome of Advanced Gastric Cancer by Multiplex Branched-Dna Liquid Chip Technology].

Beta-Tubulin III Mrna Expression and Docetaxel Sensitivity in Non-Small Cell Lung Cancer

A Novel Model Including Cxcr4 And Cdk6 As Potential Predictive Marker For Docetaxel (Doc) Sensitivity In Gastric Cancer (Gc)

Predictive Value of Microtubule-Associated Protein Tau in Patients with Recurrent and Metastatic Breast Cancer Treated with Taxane-Containing Palliative Chemotherapy

Evaluations of biomarkers associated with sensitivity to 5-fluorouracil and taxanes for recurrent/advanced breast cancer patients treated with capecitabine-based first-line chemotherapy.

Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinoma

TUBB 3 as molecular marker for improved taxane efficacy of adjuvant chemotherapy for breast cancer

Regulation of Microtubule-Associated Protein Tau (MAPT) by Mir-34C-5p Determines the Chemosensitivity of Gastric Cancer to Paclitaxel

Class III β-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response

&Lt;p>integrative Gene Expression Profiling Reveals That Dysregulated Triple Micrornas Confer Paclitaxel Resistance in Non-Small Cell Lung Cancer Via Co-Targeting MAPT</p>

Connexin 43 Modulates the Cellular Resistance to Paclitaxel via Targeting β-Tubulin in Triple-Negative Breast Cancer

Retracted: Joint Detection of Ercc1, Tubb3, and Tyms Guidance Selection of Docetaxel, 5-Fluorouracil and Cisplatin (ddp) Individual Chemotherapy in Advanced Gastric Cancer Patients (retracted Article. See Vol. 20, 29, 2015)

Relationship Between Mrna Expression of BRCA1 and Β-Tubulin III in Malignant Effusions and Ex Vivo Chemosenstitivity to Docetaxel

Influence of β-tubulin mRNA expression on post-gastrectomy paclitaxel chemotherapy and prognosis of gastric cancer